LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER Drug Patent Profile

Which patents cover Lidocaine Hydrochloride In Plastic Container, and what generic alternatives are available?

Lidocaine Hydrochloride In Plastic Container is a drug marketed by Fresenius Kabi Usa and Hospira and is included in seven NDAs.

The generic ingredient in LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Lidocaine Hydrochloride In Plastic Container

A generic version of LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER was approved as lidocaine hydrochloride by PHARMOBEDIENT on November 18^th, 1982.

Summary for LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER

US Patents:	0
Applicants:	2
NDAs:	7
Finished Product Suppliers / Packagers:	9
Raw Ingredient (Bulk) Api Vendors:	58
Clinical Trials:	2,146
Patent Applications:	4,344
DailyMed Link:	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER at DailyMed

Recent Clinical Trials for LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Vanderbilt University Medical Center	PHASE4
Assiut University	NA
Sakarya University	NA

See all LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER clinical trials

Pharmacology for LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER

Drug Class	Amide Local Anesthetic Antiarrhythmic
Physiological Effect	Local Anesthesia

US Patents and Regulatory Information for LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Fresenius Kabi Usa	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	lidocaine hydrochloride	INJECTABLE;INJECTION	088586-001	Jul 24, 1985	AP	RX	No	No
Hospira	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	lidocaine hydrochloride	INJECTABLE;INJECTION	088368-001	Jul 31, 1984		DISCN	No	No
Hospira	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	lidocaine hydrochloride	INJECTABLE;INJECTION	088326-001	Jul 31, 1984		DISCN	No	No
Hospira	LIDOCAINE HYDROCHLORIDE IN PLASTIC CONTAINER	lidocaine hydrochloride	INJECTABLE;INJECTION	088325-001	Jul 31, 1984	AP	RX	No	No

Last updated: February 5, 2026

Market Dynamics for Lidocaine Hydrochloride in Plastic Containers

Lidocaine hydrochloride, a local anesthetic, is widely used in various medical procedures. Its formulation in plastic containers is standard for clinical and pharmaceutical uses. The market dynamics are influenced by regulatory, technological, and demand-side factors.

Key Drivers

• Medical Procedure Volume: Increasing surgical, dental, and cosmetic procedures globally drive demand.
• Regulatory Approvals: Approved by authorities like the FDA, EMA, and other agencies ensures market access; ongoing approvals for new formulations impact sales.
• Preference for Plastic Containers: Plastic offers benefits such as weight reduction, reduced breakage, and ease of sterilization; growing adoption boosts market size.
• Generic Market Penetration: Post-patent expiration, generic manufacturers increase supply, stabilizing prices and expanding accessibility.

Market Constraints

• Regulatory Hurdles: Changes in drug packaging standards or safety protocols may impose new costs.
• Supply Chain Disruptions: Raw material availability, especially for plastics and active pharmaceutical ingredients (APIs), affects production.
• Pricing Pressures: Cost containment in healthcare settings pressures margins on generic and branded products.

Market Size and Growth

The global anesthetic agents market, including lidocaine, was valued at approximately USD 4 billion in 2021. Lidocaine occupies a substantial share due to its widespread use.

• Projected Compound Annual Growth Rate (CAGR): 3-4% through 2028, driven by expanding healthcare infrastructure, especially in Asia-Pacific regions.
• Regional Variations: North America and Europe account for 60% of sales, with growth in emerging markets due to increasing procedural volumes.

Competitive Environment

• Major Players: Pfizer, Hikma Pharmaceuticals, Mylan, and Teva lead production.
• Market Share: The top three accounted for 70% of global sales in 2021.
• Pricing Trends: Increased generic competition has led to pricing reductions over the past five years.

Regulatory Landscape

• Labeling and Safety Standards: Constant evolution influences packaging and delivery formats.
• Environmental Policies: Restrictions on plastic use may impact container choices, encouraging innovation towards biodegradable packaging.

---

Financial Trajectory

Revenue Projections

• Historical Revenue: Estimated at USD 400-500 million annually in global sales for products packaged in plastic containers.
• 2022-2028 Forecast: CAGR of 3-4%, resulting in potential annual revenues near USD 550 million by 2028.

Cost Factors

• Raw Materials: Plastic resins and API costs have risen by approximately 2-3% annually since 2020.
• Manufacturing: Automation and process optimization reduce unit costs but require absorption of capital expenditure upfront.
• Regulatory Compliance: Annual costs for certification, testing, and quality assurance range from USD 5-10 million per company, depending on scale.

Profitability

• Margins: Branded products maintain margins around 25-35%; generics operate closer to 15-20% due to price competition.
• Market Entry: New entrants face high regulatory barriers, but smaller firms can gain market share through niche focuses or innovative packaging.

Investment Outlook

• Research & Development: Minimal innovation occurs in container formats; focus remains on formulation improvements.
• Acquisition Potential: Larger pharmaceutical companies investing in expanded anesthesia portfolios or shifting towards more sustainable packaging offer M&A opportunities.
• Pricing Strategies: Price erosion in mature markets suggests emphasis on cost reduction and scale efficiencies.

---

Key Considerations

• The market remains mature, with incremental growth driven by procedural volume increases.
• Regulatory changes and environmental policies could restructure packaging standards, influencing costs.
• Competitive pressures force ongoing price reductions, but innovation in delivery methods or packaging may open new revenue streams.

---

Key Takeaways

• The global lidocaine hydrochloride market in plastic containers is estimated at USD 400-500 million annually, with a steady CAGR of 3-4% expected through 2028.
• Demand driven by procedural volume growth in mature and emerging markets is central to expansion; market saturation limits rapid growth.
• Cost structures are impacted by raw materials, regulatory compliance, and manufacturing efficiencies, with revenue margins generally between 15-35%.
• Regulatory evolution and sustainability initiatives present both challenges and opportunities, particularly in container innovation.
• Investment prospects hinge on capacity expansion, market consolidation, and packaging innovation.

---

FAQs

1. What factors influence the pricing of lidocaine hydrochloride in plastic containers?
   Pricing is affected by raw material costs, manufacturing efficiencies, competition from generics, and regulatory compliance obligations.

2. How does environmental policy impact the market?
   Restrictions on plastic use may increase costs due to the need for alternative packaging solutions or biodegradable plastics, influencing margins.

3. What regions are seeing fastest growth?
   Emerging markets in Asia-Pacific show higher growth rates due to expanding healthcare infrastructure, while North America and Europe are mature markets with stable demand.

4. Are there significant patent expiries affecting the market?
   Most lidocaine formulations in plastic containers are off-patent, leading to increased generic competition and price stabilization.

5. What innovations could impact the market?
   Advances in biodegradable plastics, reusable containers, or delivery systems that improve stability or ease of use may shift market dynamics.

---

References

1. Markets and Markets, "Anesthetic Agents Market," 2022.
2. IBISWorld, "Pharmaceutical Packaging in the US," 2021.
3. Grand View Research, "Global Topical Anesthetics Market," 2022.
4. FDA Drug Approvals Database, 2022.
5. Statista, "Global Pharmaceutical Market Revenue," 2022.